Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17703434rdf:typepubmed:Citationlld:pubmed
pubmed-article:17703434lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0035094lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C0003017lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C1960108lld:lifeskim
pubmed-article:17703434lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:17703434pubmed:issue2lld:pubmed
pubmed-article:17703434pubmed:dateCreated2007-8-17lld:pubmed
pubmed-article:17703434pubmed:abstractTextWe studied the effects of extremely low-dose human renin inhibition (aliskiren) with low angiotensin II receptor blockade (losartan) in a novel double-transgenic rat model harbouring both human renin and angiotensinogen genes. We found that low-dose aliskiren and low-dose losartan effectively reduced mortality and target-organ damage with minimal, non-significant, effects on blood pressure (BP). Our data suggest that renin-angiotensin system (RAS) inhibition ameliorates target-organ damage in an Ang II-driven model of hypertension. Direct renin inhibition is equally efficacious in this regard. Our study does not fully answer the question of BP-lowering versus RAS inhibition. This question is important and was at least partially addressed with our low-dose model.lld:pubmed
pubmed-article:17703434pubmed:languageenglld:pubmed
pubmed-article:17703434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:citationSubsetIMlld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703434pubmed:statusMEDLINElld:pubmed
pubmed-article:17703434pubmed:monthJunlld:pubmed
pubmed-article:17703434pubmed:issn1470-3203lld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:MeinersSilkeSlld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:DechendRalfRlld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:FiebelerAnett...lld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:MullerDominik...lld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:PilzBernhardBlld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:ShagdarsurenE...lld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:WebbRandyRlld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:GratzePetraPlld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:FeldmanDavid...lld:pubmed
pubmed-article:17703434pubmed:authorpubmed-author:DererWolfgang...lld:pubmed
pubmed-article:17703434pubmed:issnTypePrintlld:pubmed
pubmed-article:17703434pubmed:volume8lld:pubmed
pubmed-article:17703434pubmed:ownerNLMlld:pubmed
pubmed-article:17703434pubmed:authorsCompleteYlld:pubmed
pubmed-article:17703434pubmed:pagination81-4lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:meshHeadingpubmed-meshheading:17703434...lld:pubmed
pubmed-article:17703434pubmed:year2007lld:pubmed
pubmed-article:17703434pubmed:articleTitleLow-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.lld:pubmed
pubmed-article:17703434pubmed:affiliationUniversitary Medicine Berlin, Charite Campus Buch, Franz Volhard Clinic, HELIOS Klinikum-Berlin, Germany.lld:pubmed
pubmed-article:17703434pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17703434pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:185entrezgene:pubmedpubmed-article:17703434lld:entrezgene
entrez-gene:5972entrezgene:pubmedpubmed-article:17703434lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17703434lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17703434lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703434lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703434lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703434lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703434lld:pubmed